Economic Evaluation of Total Laboratory Automation in the Clinical Laboratory of a Tertiary Care Hospital
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Total laboratory automation (TLA) is an innovation in laboratory technology; however, the high up-front costs restrict its widespread adoption. To examine whether the capital investment for TLA is worthwhile, we analyzed its clinical- and cost-effectiveness for the expected payback period. Methods: Clinical chemistry tests and immunoassays performed in the clinical laboratory of a tertiary care hospital were divided into a post-TLA group, including 1,182,419 tests performed during December 2019, and a pre-TLA group, including 1,151,501 tests performed during December 2018. Laboratory information system data were used to measure clinical effectiveness, and depreciation data were used to calculate TLA costs. Results: Laboratory performance improved after TLA adoption in all four key performance indicators: mean turn-around time (TAT), representing the timeliness of result reporting, decreased by 6.1%; the 99th percentile of TAT, representing the outlier rate, decreased by 13.3%; the TAT CV, representing predictability, decreased by 70.0%; and weighted tube touch moment (wTTM), representing staff safety, improved by 77.6%. Based on these effectiveness results, economic evaluation was performed using two approaches. First, the incremental cost-effectiveness ratio and wTTM were used as the most cost-effective performance indicators. Second, the expected payback period was calculated. Considering only staff cost reduction, it was anticipated that 4.75 yrs would be needed to payback the initial investment. Conclusions: TLA can significantly enhance laboratory performance, has a relatively quick payback period, and can reduce total hospital expenses in the long term. Therefore, the capital investment for TLA adoption is considered to be worthwhile.
Abstract
Background: Total laboratory automation (TLA) is an innovation in laboratory technology; however, the high up-front costs restrict its widespread adoption. To examine whether the capital investment for TLA is worthwhile, we analyzed its clinical- and cost-effectiveness for the expected payback period. Methods: Clinical chemistry tests and immunoassays performed in the clinical laboratory of a tertiary care hospital were divided into a post-TLA group, including 1,182,419 tests performed during December 2019, and a pre-TLA group, including 1,151,501 tests performed during December 2018. Laboratory information system data were used to measure clinical effectiveness, and depreciation data were used to calculate TLA costs. Results: Laboratory performance improved after TLA adoption in all four key performance indicators: mean turn-around time (TAT), representing the timeliness of result reporting, decreased by 6.1%; the 99th percentile of TAT, representing the outlier rate, decreased by 13.3%; the TAT CV, representing predictability, decreased by 70.0%; and weighted tube touch moment (wTTM), representing staff safety, improved by 77.6%. Based on these effectiveness results, economic evaluation was performed using two approaches. First, the incremental cost-effectiveness ratio and wTTM were used as the most cost-effective performance indicators. Second, the expected payback period was calculated. Considering only staff cost reduction, it was anticipated that 4.75 yrs would be needed to payback the initial investment. Conclusions: TLA can significantly enhance laboratory performance, has a relatively quick payback period, and can reduce total hospital expenses in the long term. Therefore, the capital investment for TLA adoption is considered to be worthwhile.
참고문헌 (28)
- Melanson SEF, "How laboratory automation can help laboratories, clinicians, and patients", Lab Med, 39, pp.137~143 (2008)
- Sasaki M, "Total laboratory automation in Japan. Past, present, and the future", Clin Chim Acta, 278, pp.217~227 (1998)
- Hawker CD, "Laboratory automation : total and subtotal", Clin Lab Med, 27, pp.749~770 (2007)
- "Product guides: laboratory automation systems and workcells" (2017)[URL]
- Lippi G, "Advantages and limitations of total laboratory automation : a personal overview", Clin Chem Lab Med, 57, pp.802~811 (2019)
- Hawker CD, "Automated transport and sorting system in a large reference laboratory: part 2. Implementation of the system and performance measures over three years", Clin Chem, 48, pp.1761~1767 (2002)
- Archetti C, "Clinical laboratory automation : a case study", J Public Health Res, 6, pp.881~ (2017)
- Ellison TL, "Implementation of total laboratory automation at a tertiary care hospital in Saudi Arabia : effect on turnaround time and cost efficiency", Ann Saudi Med, 38, pp.352~357 (2018)
- Sarkozi L, "The effects of total laboratory automation on the management of a clinical chemistry laboratory. Retrospective analysis of 36 years", Clin Chim Acta, 329, pp.89~94 (2003)
- Hawkins RC, "Laboratory turnaround time", Clin Biochem Rev, 28, pp.179~194 (2007)
- Miler M, "Key performance indicators to measure improvement after implementation of total laboratory automation Abbott Accelerator a3600", J Med Syst, 42, pp.28~ (2017)
- Holland LL, "Reducing laboratory turnaround time outliers can reduce emergency department patient length of stay : an 11-hospital study", Am J Clin Pathol, 124, pp.672~674 (2005)
- Drummond MF, "Methods for the economic evaluation of health care programmes" (2015), Oxford University Press
- Threshold values for cost-effectiveness in health care Health Technology Assessment (HTA), "Cleemput I", Belgian Health Care Knowledge Centre (KCE), ~, pp.D (2008), 2008[DOI]
- "Average exchange rate by period" (2020)[URL]
- Yu HE, "Improving laboratory processes with total laboratory automation", Lab Med, 50, pp.96~102 (2019)
- Genzen JR, "Challenges and opportunities in implementing total laboratory automation", Clin Chem, 64, pp.259~264 (2018)
- Robert Hawkins, "Managing the Pre- and Post-analytical Phases of the Total Testing Process", Annals of Laboratory Medicine, 32(1), pp.5~16 (2012), 대한진단검사의학회
- Sarah W Njoroge, "Risk Management in the Clinical Laboratory", Annals of Laboratory Medicine, 34(4), pp.274~278 (2014), 대한진단검사의학회
- Roberto Verna, "Reducing Diagnostic Errors Worldwide Through Diagnostic Management Teams", Annals of Laboratory Medicine, 39(2), pp.121~124 (2019), 대한진단검사의학회[DOI]
- Sciacovelli L, "Quality indicators in laboratory medicine : the status of the progress of IFCC Working Group"Laboratory Errors and Patient Safety"project", Clin Chem Lab Med, 55, pp.348~357 (2017)
- Karadağ C, "Continual improvement of the pre-analytical process in a public health laboratory with quality indicators-based risk management", Clin Chem Lab Med, 57, pp.1530~1538 (2019)
- Seaberg RS, "The role of total laboratory automation in a consolidated laboratory network", Clin Chem, 46, pp.751~756 (2000)
- Boyd J, "Tech.Sight. Robotic laboratory automation", Science, 295, pp.517~518 (2002)
- Young DS, "Laboratory automation : smart strategies and practical applications", Clin Chem, 46, pp.740~745 (2000)
- Goswami B, "Turn around time(TAT)as a benchmark of laboratory performance", Indian J Clin Biochem, 25, pp.376~379 (2010)
- Kelley L, "Improving satisfaction performance through faster turnaround times", Radiol Manage, 33, pp.38~41 (2011)
- Howanitz JH, "Timeliness as a quality attribute and strategy", Am J Clin Pathol, 116, pp.311~315 (2001)